Vestmark Advisory Solutions’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100M Sell
1,215,609
-120
-0% -$9.63K 0.94% 14
2026
Q1
$92.1M Sell
1,215,729
-30,855
-2% -$2.41M 1.02% 12
2025
Q4
$93.3M Buy
1,246,584
+112,416
+10% +$8.39M 1.26% 11
2025
Q3
$83.4M Buy
1,134,168
+132,904
+13% +$9.53M 1.59% 9
2025
Q2
$70.9M Buy
1,001,264
+661,762
+195% +$44.1M 1.02% 19
2025
Q1
$21.6M Buy
339,502
+45,198
+15% +$2.83M 0.56% 36
2024
Q4
$17.2M Buy
294,304
+37,339
+15% +$2.33M 0.59% 34
2024
Q3
$17M Buy
256,965
+29,982
+13% +$1.92M 0.63% 34
2024
Q2
$14.2M Buy
226,983
+29,603
+15% +$1.85M 0.59% 34
2024
Q1
$12.4M Buy
+197,380
New +$11.8M 0.53% 38

Other funds holding JIRE

Vestmark Advisory Solutions's JIRE Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 0.01% in Q2 2026, selling an estimated $9.63K and leaving 1,215,609 shares worth $100M. The position accounts for 0.94% of the portfolio, ranked #14.

Vestmark Advisory Solutions first reported a position in JIRE in Q1 2024 and has held it in 10 quarters since. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Vestmark Advisory Solutions held 1,215,609 shares of JPMorgan International Research Enhanced Equity ETF worth $100M as of Q2 2026.
  • Vestmark Advisory Solutions sold 120 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $9.63K.
  • JPMorgan International Research Enhanced Equity ETF made up 0.94% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #14 holding.
  • Vestmark Advisory Solutions first reported a position in JPMorgan International Research Enhanced Equity ETF in Q1 2024 and has held it in 10 quarters since.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.